Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.01SPGP 1.715ZUQ.TO 1.27NVDA 7.15GL 2.43MRK -3.06IEMG 1.96GEV 34.91
Patheon (PTI.TO)

Patheon (PTI.TO)

0.00
-0.00 (0.00%)
6 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
TOP PICK

Patheon(PTI.TO)

Apr 04, 2003
Excellent prices.
Photo of David BaskinDavid BaskinUnlock Rating
$13.31

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Patheon(PTI.TO)

Mar 17, 2003
Has disappointed on earnings.
Photo of David BurrowsDavid BurrowsUnlock Rating
$13.20

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Patheon(PTI.TO)

Nov 01, 2002
Looking for about 30% growth. Their new acquisition in the US should be good for growth there.
Photo of Mike WeirMike WeirUnlock Rating
$14.50

Stock price when the opinion was issued

biotechnologypharmaceutical
HOLD

Patheon(PTI.TO)

Sep 26, 2002
Fair market vaue is $20. Runs into stiff technical resistance at $15.
Photo of Ross HealyRoss HealyUnlock Rating
$13.03

Stock price when the opinion was issued

biotechnologypharmaceutical
HOLD

Patheon(PTI.TO)

Sep 13, 2002
Good earnings. A little pricey now.
Photo of Clos OlssonClos OlssonUnlock Rating
$13.00

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Patheon(PTI.TO)

Sep 12, 2002
Buy on a pull back. Well run.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$13.00

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Patheon(PTI.TO)

Aug 21, 2002
(Was a top pick on Mar 15. Down 8.4%.)
Photo of Jonathen Wellum, B. Comm, B. ScJonathen Wellum, B. Comm, B. ScUnlock Rating
$11.98

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

Jul 11, 2002
Likes.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$11.43

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

May 29, 2002
Long term should be good. Short term doesn't see too much movement.
Photo of Michael SmedleyMichael SmedleyUnlock Rating
$11.10

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Patheon(PTI.TO)

May 17, 2002
High valuation. Return on equity is poor.
Photo of Bruce CooperBruce CooperUnlock Rating
$11.60

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Patheon(PTI.TO)

May 07, 2002
Fully priced.
Photo of Pierre BernardPierre BernardUnlock Rating
$12.39

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Patheon(PTI.TO)

Apr 08, 2002
Multiple is too high. Would prefer $10. Good company.
Photo of Bruce Campbell (1)Bruce Campbell (1)Unlock Rating
$13.14

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Patheon(PTI.TO)

Apr 05, 2002
Pharmaceuticals are doing more outsourcing.
Photo of Jonathen Wellum, B. Comm, B. ScJonathen Wellum, B. Comm, B. ScUnlock Rating
$12.79

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Patheon(PTI.TO)

Mar 28, 2002
At fair value now.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$12.89

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

Patheon(PTI.TO)

Mar 26, 2002
At a fair value. Has tracked between $12 and $14.
Photo of Michael SmedleyMichael SmedleyUnlock Rating
$12.50

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 121 to 135 of 194 entries
The ultimate 360° Tracker Your financial life in one place, automatically

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.47$36.78
ET -0.025$19.045
MAIR 0$
RKLB 6.095$108.485
SESG-O 0$

Today's Top Picks

HMP.TO 0.01$9.76
SPGP 1.715$122.105
ZUQ.TO 1.27$108.74
NVDA 7.15$212.34
GL 2.43$169.19

Popular Articles

Latest Sell Signals

PRGO -0.14$10.85
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica